| 1 | Comparative Effectiveness of Antihypertensive Medications in Children With Chronic Kidney Disease. (Denburg MR, Goodwin Davies AJ, Maltenfort MG, Mitsnefes MM, Flynn JT, Neu AM, Dixon BP, Glenn DA, Gluck CA, Harshman LA, Katsoufis CP, Leonard MB, Modi ZJ, Pan CG, Patel HP, Patterson LT, Verghese PS, Wilson AC, Jovanovska A, Levondosky R, Levondosky M, Dickinson K, Wieand K, Razzaghi H, Li L, Chen Y, Forrest CB, PRESERVE consortium) JAMA Pediatr 2026 May 01;180(5):546-555 5 Citations |
| 2 | Hyperglycemia and Severe Medical Outcomes in Calcium Channel Blocker Exposures Reported to United States Poison Centers. (Brenner MA, Zosel AE, Feldman RJ, Stanton MT) WMJ 2025;124(4):333-337 |
| 1 | Dehydroepiandrosterone (DHEA), a circulating steroid hormone precursor produced potent vasorelaxation in rat aorta and mesenteric arteries through blockade of L-type voltage-dependent calcium channels. (Mishra D, Yadav P, Iqbal H, Parashar S, Negi AS, Chanda D) Microvasc Res 2025 Jan;157:104758 6 Citations |
| 1 | Initial Antihypertensive Regimens in Newly Treated Patients: Real World Evidence From the OneFlorida+ Clinical Research Network. (Smith SM, Winterstein AG, Gurka MJ, Walsh MG, Keshwani S, Libby AM, Hogan WR, Pepine CJ, Cooper-DeHoff RM) J Am Heart Assoc 2023 Jan 03;12(1):e026652 17 Citations |
| 1 | Phenoxybenzamine is no longer the standard agent used for alpha blockade before adrenalectomy for pheochromocytoma: A national study of 552 patients. (Kuo EJ, Chen L, Wright JD, McManus CM, Lee JA, Kuo JH) Surgery 2023 Jan;173(1):19-25 13 Citations |
| 1 | Enhanced T-type calcium channel 3.2 activity in sensory neurons contributes to neuropathic-like pain of monosodium iodoacetate-induced knee osteoarthritis. (Shin SM, Cai Y, Itson-Zoske B, Qiu C, Hao X, Xiang H, Hogan QH, Yu H) Mol Pain 2020;16:1744806920963807 28 Citations |
| 1 | Persistent Hyperinsulinemia Following High-Dose Insulin Therapy: A Case Report. (Corcoran JN, Jacoby KJ, Olives TD, Bangh SA, Cole JB) J Med Toxicol 2020 Oct;16(4):465-469 14 Citations |
| 2 | Update on Pheochromocytoma and Paraganglioma from the SSO Endocrine and Head and Neck Disease Site Working Group, Part 2 of 2: Perioperative Management and Outcomes of Pheochromocytoma and Paraganglioma. (Patel D, Phay JE, Yen TWF, Dickson PV, Wang TS, Garcia R, Yang AD, Kim LT, Solórzano CC) Ann Surg Oncol 2020 May;27(5):1338-1347 31 Citations |
| 1 | AAV-encoded CaV2.2 peptide aptamer CBD3A6K for primary sensory neuron-targeted treatment of established neuropathic pain. (Yu H, Shin SM, Xiang H, Chao D, Cai Y, Xu H, Khanna R, Pan B, Hogan QH) Gene Ther 2019 Aug;26(7-8):308-323 27 Citations |
| 1 | Recording SOCE Activity in Neurons by Patch-Clamp Electrophysiology and Microfluorometric Calcium Imaging. (Wu HE, Gemes G, Hogan QH) Methods Mol Biol 2018;1843:41-53 2 Citations |
| 1 | The quest for endothelial atypical cannabinoid receptor: BKCa channels act as cellular sensors for cannabinoids in in vitro and in situ endothelial cells. (Bondarenko AI, Panasiuk O, Drachuk K, Montecucco F, Brandt KJ, Mach F) Vascul Pharmacol 2018 Mar;102:44-55 25 Citations |
| 1 | Diethyl-4,4'-dihydroxy-8,3'-neolign-7,7'-dien-9,9'-dionate exhibits antihypertensive activity in rats through increase in intracellular cGMP level and blockade of calcium channels. (Singh A, Kumar BS, Alam S, Iqbal H, Shafiq M, Khan F, Negi AS, Hanif K, Chanda D) Eur J Pharmacol 2017 Mar 15;799:84-93 15 Citations |
| 3 | Best time window for the use of calcium-modulating agents to improve functional recovery in injured peripheral nerves-An experiment in rats. (Yan Y, Shen FY, Agresti M, Zhang LL, Matloub HS, LoGiudice JA, Havlik R, Li J, Gu YD, Yan JG) J Neurosci Res 2017 Sep;95(9):1786-1795 1 Citation |
| 1 | The Association Between Antihypertensive Medication Nonadherence and Visit-to-Visit Variability of Blood Pressure: Findings From the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. (Kronish IM, Lynch AI, Oparil S, Whittle J, Davis BR, Simpson LM, Krousel-Wood M, Cushman WC, Chang TI, Muntner P) Hypertension 2016 Jul;68(1):39-45 94 Citations |
| 1 | Thrombospondin-4 divergently regulates voltage-gated Ca2+ channel subtypes in sensory neurons after nerve injury. (Pan B, Guo Y, Wu HE, Park J, Trinh VN, Luo ZD, Hogan QH) Pain 2016 Sep;157(9):2068-2080 33 Citations |
| 1 | Spinal activity of interleukin 6 mediates myelin basic protein-induced allodynia. (Ko JS, Eddinger KA, Angert M, Chernov AV, Dolkas J, Strongin AY, Yaksh TL, Shubayev VI) Brain Behav Immun 2016 Aug;56:378-89 30 Citations |
| 3 | Regulation of voltage-gated Ca(2+) currents by Ca(2+)/calmodulin-dependent protein kinase II in resting sensory neurons. (Kostic S, Pan B, Guo Y, Yu H, Sapunar D, Kwok WM, Hudmon A, Wu HE, Hogan QH) Mol Cell Neurosci 2014 Sep;62:10-8 13 Citations |
| 1 | Effect of chlorthalidone, amlodipine, and lisinopril on visit-to-visit variability of blood pressure: results from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. (Muntner P, Levitan EB, Lynch AI, Simpson LM, Whittle J, Davis BR, Kostis JB, Whelton PK, Oparil S) J Clin Hypertens (Greenwich) 2014 May;16(5):323-30 54 Citations |
| 1 | Opposing roles of smooth muscle BK channels and ryanodine receptors in the regulation of nerve-evoked constriction of mesenteric resistance arteries. (Krishnamoorthy G, Sonkusare SK, Heppner TJ, Nelson MT) Am J Physiol Heart Circ Physiol 2014 Apr 01;306(7):H981-8 17 Citations |
| 1 | Risk of hospitalized gastrointestinal bleeding in persons randomized to diuretic, ACE-inhibitor, or calcium-channel blocker in ALLHAT. (Phillips W, Piller LB, Williamson JD, Whittle J, Jafri SZ, Ford CE, Einhorn PT, Oparil S, Furberg CD, Grimm RH Jr, Alderman MH, Davis BR, Probstfield JL, ALLHAT Collaborative Research Group) J Clin Hypertens (Greenwich) 2013 Nov;15(11):825-32 8 Citations |
| 3 | The effect of calcium modulating agents on peripheral nerve recovery after crush. (Yan JG, Zhang LL, Agresti M, Logiudice J, Yan YH, Wang Z, Sanger JR, Matloub HS) J Neurosci Methods 2013 Jul 15;217(1-2):54-62 13 Citations |
| 1 | N-Arachidonoyl glycine suppresses Na⁺/Ca²⁺ exchanger-mediated Ca²⁺ entry into endothelial cells and activates BK(Ca) channels independently of GPCRs. (Bondarenko AI, Drachuk K, Panasiuk O, Sagach V, Deak AT, Malli R, Graier WF) Br J Pharmacol 2013 Jun;169(4):933-48 25 Citations |
| 1 | Tocolytic therapy for preterm delivery: systematic review and network meta-analysis. (Haas DM, Caldwell DM, Kirkpatrick P, McIntosh JJ, Welton NJ) BMJ 2012 Oct 09;345:e6226 323 Citations |
| 3 | Ca²⁺-dependent regulation of Ca²⁺ currents in rat primary afferent neurons: role of CaMKII and the effect of injury. (Tang Q, Bangaru ML, Kostic S, Pan B, Wu HE, Koopmeiners AS, Yu H, Fischer GJ, McCallum JB, Kwok WM, Hudmon A, Hogan QH) J Neurosci 2012 Aug 22;32(34):11737-49 27 Citations |
| 1 | Evidence-based guideline update: pharmacologic treatment for episodic migraine prevention in adults: report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society. (Silberstein SD, Holland S, Freitag F, Dodick DW, Argoff C, Ashman E, Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society) Neurology 2012 Apr 24;78(17):1337-45 827 Citations |
| 1 | Acute restraint stress enhances hippocampal endocannabinoid function via glucocorticoid receptor activation. (Wang M, Hill MN, Zhang L, Gorzalka BB, Hillard CJ, Alger BE) J Psychopharmacol 2012 Jan;26(1):56-70 128 Citations |
| 1 | Extracellular signal-regulated kinase signaling in the ventral tegmental area mediates cocaine-induced synaptic plasticity and rewarding effects. (Pan B, Zhong P, Sun D, Liu QS) J Neurosci 2011 Aug 03;31(31):11244-55 58 Citations |
| 2 | Stable EET urea agonist and soluble epoxide hydrolase inhibitor regulate rat pulmonary arteries through TRPCs. (Liu Y, Wang R, Li J, Rao J, Li W, Falck JR, Manthati VL, Medhora M, Jacobs ER, Zhu D) Hypertens Res 2011 May;34(5):630-9 19 Citations |
| 2 | Subtype-specific reduction of voltage-gated calcium current in medium-sized dorsal root ganglion neurons after painful peripheral nerve injury. (McCallum JB, Wu HE, Tang Q, Kwok WM, Hogan QH) Neuroscience 2011 Apr 14;179:244-55 29 Citations |
| 1 | Calcium signaling in intact dorsal root ganglia: new observations and the effect of injury. (Gemes G, Rigaud M, Koopmeiners AS, Poroli MJ, Zoga V, Hogan QH) Anesthesiology 2010 Jul;113(1):134-46 25 Citations |
| 1 | Inhibition of stored Ca2+ release disrupts convergence-related cell movements in the lateral intermediate mesoderm resulting in abnormal positioning and morphology of the pronephric anlagen in intact zebrafish embryos. (Lam PY, Webb SE, Leclerc C, Moreau M, Miller AL) Dev Growth Differ 2009 May;51(4):429-42 10 Citations |
| 2 | Treatment of acute postoperative hypertension in cardiac surgery patients: an efficacy study of clevidipine assessing its postoperative antihypertensive effect in cardiac surgery-2 (ESCAPE-2), a randomized, double-blind, placebo-controlled trial. (Singla N, Warltier DC, Gandhi SD, Lumb PD, Sladen RN, Aronson S, Newman MF, Corwin HL, ESCAPE-2 Study Group) Anesth Analg 2008 Jul;107(1):59-67 97 Citations |
| 1 | Third-degree AV block from extended-release diltiazem ingestion in a nine-month-old. (Wills BK, Liu JM, Wahl M) J Emerg Med 2010 Apr;38(3):328-31 4 Citations |
| 1 | Contribution of calcium channel subtypes to the intracellular calcium signal in sensory neurons: the effect of injury. (Fuchs A, Rigaud M, Sarantopoulos CD, Filip P, Hogan QH) Anesthesiology 2007 Jul;107(1):117-27 27 Citations |
| 2 | Contribution of epoxyeicosatrienoic acids to the hypoxia-induced activation of Ca2+ -activated K+ channel current in cultured rat hippocampal astrocytes. (Yamaura K, Gebremedhin D, Zhang C, Narayanan J, Hoefert K, Jacobs ER, Koehler RC, Harder DR) Neuroscience 2006 Dec;143(3):703-16 46 Citations |
| 1 | Temporal coupling of cyclic AMP and Ca/calmodulin-stimulated adenylyl cyclase to the circadian clock in chick retinal photoreceptor cells. (Chaurasia SS, Haque R, Pozdeyev N, Jackson CR, Iuvone PM) J Neurochem 2006 Nov;99(4):1142-50 32 Citations |
| 2 | Negative inotropic drugs alter indexes of cytosolic [Ca(2+)]-left ventricular pressure relationships after ischemia. (Camara AK, Chen Q, Rhodes SS, Riess ML, Stowe DF) Am J Physiol Heart Circ Physiol 2004 Aug;287(2):H667-80 5 Citations |
| 1 | Slow channel calcium inhibition blocks proinflammatory gene signaling and reduces macrophage responsiveness. (Cuschieri J, Gourlay D, Garcia I, Jelacic S, Maier RV) J Trauma 2002 Mar;52(3):434-42 40 Citations |
| 2 | Cannabinoid receptor agonists inhibit depolarization-induced calcium influx in cerebellar granule neurons. (Nogueron MI, Porgilsson B, Schneider WE, Stucky CL, Hillard CJ) J Neurochem 2001 Oct;79(2):371-81 44 Citations |
| 1 | Cannabinoid CB(1) receptor agonists produce cerebellar dysfunction in mice. (Patel S, Hillard CJ) J Pharmacol Exp Ther 2001 May;297(2):629-37 82 Citations |
| 1 | Gadolinium prevents stretch-mediated contractile dysfunction in isolated papillary muscles. (Nicolosi AC, Kwok CS, Contney SJ, Olinger GN, Bosnjak ZJ) Am J Physiol Heart Circ Physiol 2001 Mar;280(3):H1122-8 16 Citations |
| 1 | Intranasal civamide for the acute treatment of migraine headache. (Diamond S, Freitag F, Phillips SB, Bernstein JE, Saper JR) Cephalalgia 2000 Jul;20(6):597-602 80 Citations |
| 2 | Cannabinoid CB1 receptor-mediated inhibition of prolactin release and signaling mechanisms in GH4C1 cells. (Ho BY, Stadnicka A, Prather PL, Buckley AR, Current LL, Bosnjak ZJ, Kwok WM) Endocrinology 2000 May;141(5):1675-85 26 Citations |
| 1 | Effects of CB(1) cannabinoid receptor activation on cerebellar granule cell nitric oxide synthase activity. (Hillard CJ, Muthian S, Kearn CS) FEBS Lett 1999 Oct 08;459(2):277-81 95 Citations |
| 1 | New approaches to prevention and treatment of radial artery graft vasospasm. (Cable DG, Caccitolo JA, Pearson PJ, O'Brien T, Mullany CJ, Daly RC, Orszulak TA, Schaff HV) Circulation 1998 Nov 10;98(19 Suppl):II15-21; discussion II21-2 117 Citations |
| 1 | Selective effects of the endogenous cannabinoid arachidonylethanolamide (anandamide) on regional cerebral blood flow in the rat. (Stein EA, Fuller SA, Edgemond WS, Campbell WB) Neuropsychopharmacology 1998 Dec;19(6):481-91 21 Citations |
| 1 | Effects of the optical isomers of verapamil on electrophysiological properties of the heart in conscious dogs. (Takahata O, Krolikowski JG, McCallum JB, Lathrop DA, Bosnjak ZJ) Eur J Pharmacol 1998 Aug 21;355(2-3):159-66 2 Citations |
| 1 | Inhibition of Na+/H+ exchange stimulates CCK secretion in STC-1 cells. (Prpic V, Fitz JG, Wang Y, Raymond JR, Garnovskaya MN, Liddle RA) Am J Physiol 1998 Oct;275(4):G689-95 4 Citations |
| 1 | Impaired exercise capacity late after cardiac transplantation: influence of chronotropic incompetence, hypertension, and calcium channel blockers. (Quigg R, Salyer J, Mohanty PK, Simpson P) Am Heart J 1998 Sep;136(3):465-73 28 Citations |
| 3 | Cardiovascular effects of verapamil enantiomer combinations in conscious dogs. (Pagel PS, Hettrick DA, Lowe D, Gowrie PW, Kersten JR, Bosnjak ZJ, Warltier DC) Eur J Pharmacol 1998 May 08;348(2-3):213-21 12 Citations |
| 1 | Differential roles of myocardial Ca2+ channels and Na+/Ca2+ exchange in myocardial reperfusion injury in open chest dogs: relative roles during ischemia and reperfusion. (Smart SC, Sagar KB, Warltier DC) Cardiovasc Res 1997 Dec;36(3):337-46 20 Citations |
| 1 | Injury to the Ca2+ ATPase of the sarcoplasmic reticulum in anesthetized dogs contributes to myocardial reperfusion injury. (Smart SC, Sagar KB, el Schultz J, Warltier DC, Jones LR) Cardiovasc Res 1997 Nov;36(2):174-84 20 Citations |
| 1 | Calcium channel blockers. Consensus amid controversy. (Kochar MS, Qurashi MI) Postgrad Med 1997 Dec;102(6):127-8, 133-6 1 Citation |
| 1 | Myogenic constriction of human coronary arterioles. (Miller FJ Jr, Dellsperger KC, Gutterman DD) Am J Physiol 1997 Jul;273(1 Pt 2):H257-64 104 Citations |
| 1 | Alpha-adrenoceptor activation induces rhythmic contractile activity in carotid arteries from young, not adult, rats. (Eddinger TJ, Ratz PH) Acta Physiol Scand 1997 Feb;159(2):123-9 6 Citations |
| 1 | Regulation of melatonin synthesis in rainbow trout (Oncorhyncus mykiss) pineal organs: effects of calcium depletion and calcium channel drugs. (Gasser PJ, Gern WA) Gen Comp Endocrinol 1997 Feb;105(2):210-7 7 Citations |
| 1 | Antiarrhythmic action of the new calcium antagonist [1,2,5-trimethyl-4-phenyl-4-beta-(N-cyanoethyl-N-4'-methoxybenzyl) -ethylamino]piperidine dihydrochloride. (Alexanian AR, Arutyunian NS, Galoyan AA) Arzneimittelforschung 1996 Dec;46(12):1110-3 3 Citations |
| 1 | Pharmacological management of spinal cord injury: current status of drugs designed to augment functional recovery of the injured human spinal cord. (Greene KA, Marciano FF, Sonntag VK) J Spinal Disord 1996 Oct;9(5):355-66 15 Citations |
| 1 | Physiological and behavioural effects of the endogenous cannabinoid, arachidonylethanolamide (anandamide), in the rat. (Stein EA, Fuller SA, Edgemond WS, Campbell WB) Br J Pharmacol 1996 Sep;119(1):107-14 73 Citations |
| 1 | Inhibition of voltage-gated Ca2+ channel activity in small cell lung carcinoma by the Ca2+/calmodulin-dependent protein kinase inhibitor KN-62 (1-[N,O-bis(5-isoquinolinesulfonyl)-N-methyl-L-tyrosyl]-4-phenylpiperaz ine) . (Williams CL, Porter RA, Phelps SH) Biochem Pharmacol 1995 Dec 22;50(12):1979-85 14 Citations |
| 1 | The pharmacology of medications used in treating headache. (Solomon GD) Semin Pediatr Neurol 1995 Jun;2(2):165-77 17 Citations |
| 1 | Advances in migraine management. (Lewis TA, Solomon GD) Cleve Clin J Med 1995;62(3):148-55 10 Citations |
| 1 | The renal medulla and hypertension. (Cowley AW Jr, Mattson DL, Lu S, Roman RJ) Hypertension 1995 Apr;25(4 Pt 2):663-73 217 Citations |
| 1 | Beta-adrenergic receptor antagonist antihypertensive medications impair arousal-induced modulation of working memory in elderly humans. (Nielson KA, Jensen RA) Behav Neural Biol 1994 Nov;62(3):190-200 98 Citations |
| 1 | Strategies for preventing diabetic nephropathy. (Raymond JR, Arthur JM, Kovalik E) N C Med J 1994 Aug;55(8):362-9 |
| 1 | Alcohol and hypertension. (Grogan JR, Kochar MS) Arch Fam Med 1994 Feb;3(2):150-4 37 Citations |
| 2 | Left ventricular diastolic function in the normal and diseased heart. Perspectives for the anesthesiologist (2). (Pagel PS, Grossman W, Haering JM, Warltier DC) Anesthesiology 1993 Nov;79(5):1104-20 41 Citations |
| 1 | Treatment considerations in headache and associated medical disorders. (Solomon GD) J Pain Symptom Manage 1993 Feb;8(2):73-80 3 Citations |
| 1 | Effect of K+ channel blockade with tetraethylammonium on anesthetic-induced relaxation in canine cerebral and coronary arteries. (Marijic J, Buljubasïc N, Coughlan MG, Kampine JP, Bosnjak ZJ) Anesthesiology 1992 Nov;77(5):948-55 17 Citations |
| 2 | Comparative cardiac effects of KT-362 and verapamil in isolated heart--correlation to calcium channel current depression. (Buljubasic N, Marijic J, Stowe DF, Gross GJ, Kampine JP, Bosnjak ZJ) J Cardiovasc Pharmacol 1991 Oct;18(4):594-604 11 Citations |
| 1 | High affinity binding of the calcium channel blocker, (+)-[methyl-3H]PN200-110(3HPN) in rat brain. (Magill SB, Stone JS, Parmar SS) Physiol Behav 1989 Jul;46(1):101-4 4 Citations |
| 1 | Reduction of myocardial ischemia-reperfusion injury by KT-362, a new intracellular calcium antagonist in anesthetized dogs. (Pelc LR, Farber NE, Warltier DC, Gross GJ) J Cardiovasc Pharmacol 1989 Apr;13(4):586-93 13 Citations |
| 1 | Effect of KT-362, a putative intracellular calcium antagonist, on norepinephrine-induced contractions and inositol monophosphate accumulation in canine femoral artery. (Eskinder H, Hillard CJ, Wilke RA, Gross GJ) J Cardiovasc Pharmacol 1989 Mar;13(3):502-7 16 Citations |
| 1 | Effects of nisoldipine on coronary collateral perfusion and hemodynamics in chronically instrumented dogs. (Kenny D, Hartman JC, Brooks HL, Warltier DC) Pharmacology 1989;38(4):263-71 |
| 1 | Hemodynamic and electrocardiographic actions of the new intracellular calcium antagonist, KT-362, in the conscious dog. (Hartman JC, Al-Wathiqui MH, Brooks HL, Gross GJ, Warltier DC) Pharmacology 1988;37(6):376-84 3 Citations |
| 1 | Cardiovascular actions of a new dihydropyridine calcium antagonist, 8363-S: comparison with nifedipine and nicardipine in awake, unsedated dogs. (Wynsen JC, Shimshak TM, Preuss KC, Hardman HF, Warltier DC) J Cardiovasc Pharmacol 1987 Jul;10(1):30-7 4 Citations |
| 1 | Effects of intracoronary Bay k 8644, a calcium channel agonist, in anesthetized dogs. (Pelc LR, Gross GJ, Brooks HL, Warltier DC) J Cardiovasc Pharmacol 1986;8(6):1223-8 5 Citations |
| 1 | Effect of nimodipine on cerebral metabolism during ischemia and recirculation in the mongolian gerbil. (Heffez DS, Passonneau JV) J Cereb Blood Flow Metab 1985 Dec;5(4):523-8 43 Citations |
| 1 | Slow channel calcium activators, a new group of pharmacological agents. (Preuss KC, Gross GJ, Brooks HL, Warltier DC) Life Sci 1985 Oct 07;37(14):1271-8 33 Citations |
| 1 | Comparative efficacy of calcium antagonist drugs in the prophylaxis of migraine. (Solomon GD) Headache 1985 Oct;25(7):368-71 34 Citations |
| 1 | Cardiac and systemic hemodynamic actions of the slow channel calcium blocking agent, KB-944. (Pelc LR, Gross GJ, Warltier DC) Gen Pharmacol 1985;16(6):585-90 1 Citation |
| 1 | Cardiovascular effects of the nifedipine analog, CGP 28 392, in the conscious dog. (Preuss KC, Cheung NL, Brooks HL, Warltier DC) J Cardiovasc Pharmacol 1984;6(5):949-53 20 Citations |
| 1 | Comparative actions of dihydropyridine slow channel calcium blocking agents in conscious dogs: systemic and coronary hemodynamics with and without combined beta adrenergic blockade. (Warltier DC, Zyvoloski MG, Gross GJ, Brooks HL) J Pharmacol Exp Ther 1984 Aug;230(2):367-75 40 Citations |
| 1 | Comparative actions of dihydropyridine slow channel calcium blocking agents in conscious dogs: alterations in baroreflex sensitivity. (Warltier DC, Zyvoloski MG, Gross GJ, Brooks HL) J Pharmacol Exp Ther 1984 Aug;230(2):376-82 24 Citations |
| 1 | Selective improvement in subendocardial perfusion distal to a flow-limiting coronary artery stenosis: effects of the new calcium channel blocking agent, FR 34235, nifedipine and diltiazem. (Gross GJ, Warltier DC) J Pharmacol Exp Ther 1984 Mar;228(3):531-6 16 Citations |
| 1 | Comparative effects of two slow channel calcium entry blockers, FR 34235 and nifedipine, on true coronary collateral blood flow. (Gross GJ, Warltier DC, Hardman HF) J Cardiovasc Pharmacol 1984;6(1):61-7 21 Citations |
| 1 | The temperature-sensitivity of slow channel calcium blockers in relation to their effect upon the calcium paradox. (Baker JE, Hearse DJ) Eur Heart J 1983 Dec;4 Suppl H:97-103 4 Citations |
| 1 | Slow calcium channel blockers and the calcium paradox: comparative studies in the rat with seven drugs. (Baker JE, Hearse DJ) J Mol Cell Cardiol 1983 Jul;15(7):475-85 24 Citations |
| 1 | The slow-channel calcium blocking agent, nitrendipine, and coronary collateral blood flow. (Warltier DC, Lamping KA, Zyvoloski MG, Gross GJ, Brooks HL) J Cardiovasc Pharmacol 1983;5(2):272-7 6 Citations |
| 1 | Comparative effects of FR 34235, a new slow channel calcium blocker, and nifedipine on hemodynamics and myocardial oxygen consumption in the anesthetized dog. (Gross GJ, Warltier DC, Hardman HF) Gen Pharmacol 1983;14(6):677-80 14 Citations |
| 1 | The effect of diltiazem, a calcium channel blocking agent, on vasoconstrictor responses to norepinephrine, serotonin and potassium depolarization in canine coronary and femoral arteries. (Mullett M, Gharaibeh M, Warltier DC, Gross GJ) Gen Pharmacol 1983;14(2):259-64 9 Citations |
| 1 | Myocardial perfusion distal to an acute or chronic coronary artery occlusion: effects of diltiazem and nifedipine. (Zyvoloski MG, Brooks HL, Gross GJ, Warltier DC) J Pharmacol Exp Ther 1982 Aug;222(2):494-500 33 Citations |
| 1 | Calcium channel blockers in migraine. (Solomon GD) Lancet 1982 Jul 17;2(8290):162 8 Citations |
| 1 | Beneficial effects of the dihydropyridine calcium antagonist, FR 34235, in a chronic coronary occlusion model. (Warltier DC, Zyvoloski MG, Brooks HL, Gross GJ) Eur J Pharmacol 1982 May 07;80(1):149-53 17 Citations |
© 2026 Clinical & Translational Science Institute